DEK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.141400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.516600E-01
Normal-vs-Stage2
3.613400E-01
Normal-vs-Stage3
7.163600E-02
Normal-vs-Stage4
8.618200E-01
Stage1-vs-Stage2
9.148200E-01
Stage1-vs-Stage3
4.320600E-01
Stage1-vs-Stage4
3.694200E-01
Stage2-vs-Stage3
2.633400E-01
Stage2-vs-Stage4
1.849240E-01
Stage3-vs-Stage4
1.228630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.181600E-01
Normal-vs-AfricanAmerican
4.943000E-01
Normal-vs-Asian
2.309400E-01
Caucasian-vs-AfricanAmerican
5.933000E-01
Caucasian-vs-Asian
6.546200E-01
AfricanAmerican-vs-Asian
4.214400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.990200E-01
Normal-vs-Female
3.543800E-01
Male-vs-Female
4.951200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.080160E-01
Normal-vs-Age(41-60Yrs)
5.586600E-01
Normal-vs-Age(61-80Yrs)
2.318800E-01
Normal-vs-Age(81-100Yrs)
3.897000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.902560E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.343800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.429000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.056100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.565000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.187000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.227180E-01
Normal-vs-Daily Drinker
1.123230E-01
Normal-vs-Weekly Drinker
1.970590E-01
Normal-vs-Occasional Drinker
6.186800E-01
Normal-vs-Social Drinker
4.218400E-01
Non Drinker-vs-Daily Drinker
5.239200E-01
Non Drinker-vs-Weekly Drinker
7.484000E-01
Non Drinker-vs-Occasional Drinker
1.417420E-01
Non Drinker-vs-Social Drinker
3.211200E-01
Daily Drinker-vs-Weekly Drinker
4.320800E-01
Daily Drinker-vs-Occasional Drinker
8.341700E-02
Daily Drinker-vs-Social Drinker
1.815400E-01
Weekly Drinker-vs-Occasional Drinker
3.537800E-01
Weekly Drinker-vs-Social Drinker
5.722600E-01
Occasional Drinker-vs-Social Drinker
6.969000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.891800E-01
Normal-vs-Grade 2
8.584400E-01
Normal-vs-Grade 3
8.255800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.102400E-02
Grade 1-vs-Grade 3
1.316310E-02
Grade 1-vs-Grade 4
9.891800E-01
Grade 2-vs-Grade 3
5.364600E-01
Grade 2-vs-Grade 4
8.584400E-01
Grade 3-vs-Grade 4
8.255800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.577600E-01
Normal-vs-NonDiabetic
2.102600E-01
Diabetic-vs-NonDiabetic
7.792600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.208000E-02
Normal-vs-NoPancreatitis
2.753200E-01
Pancreatitis-vs-NoPancreatitis
1.558770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.879600E-01
Normal-vs-N1
3.632200E-01
N0-vs-N1
6.720600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.197600E-01
Normal-vs-TP53-NonMutant
4.767600E-01
TP53-Mutant-vs-TP53-NonMutant
2.263600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
